Methenamine Hippurate Eql Pharma

Active Ingredient:: Methenamine Hippurate
Origin:: EU

Methenamine Hippurate Eql Pharma (Methenamine Hippurate)

Q: What is methenamine hippurate used for?

Methenamine hippurate is used as a urinary antiseptic to prevent recurrent urinary tract infections and to treat uncomplicated urinary tract infections. It works by creating an environment in the urine that is hostile to bacterial growth, helping to reduce infection frequency and aid symptom resolution.

Q: How does methenamine hippurate work?

After oral intake, methenamine hippurate is excreted unchanged in the urine. In acidic urine (pH < 6) it hydrolyzes, releasing formaldehyde and ammonia. Formaldehyde acts as a broad‑spectrum bactericidal agent, while ammonia further discourages bacterial survival, together providing antiseptic activity within the urinary tract.

Q: What is the usual dose of methenamine hippurate?

The specific dose of methenamine hippurate is determined by the prescribing healthcare professional based on the patient’s condition, renal function, and urine pH. Dosage regimens may vary, and the prescriber will provide individualized instructions that should be followed exactly.

Q: Is methenamine hippurate safe during pregnancy or breastfeeding?

Safety data for methenamine hippurate in pregnancy and lactation are limited, and the product does not have an established pregnancy category. Healthcare providers should weigh potential benefits against possible risks before prescribing to pregnant or nursing women, and a risk‑benefit assessment is essential.

Q: How do I order Methenamine Hippurate Eql Pharma from GNH India?

To place an order, visit the product page on gnhindia.com, submit an enquiry with the required quantity, and provide your institutional or trade credentials. GNH India’s team will verify your details, then respond with pricing, availability, shipping options, and any necessary import documentation.

Q: How does methenamine hippurate compare with other urinary antiseptics?

Methenamine hippurate differs from other urinary antiseptics such as nitrofurantoin or trimethoprim‑sulfamethoxazole in that it requires acidic urine to become active, releasing formaldehyde. This mechanism provides a broad antibacterial effect without relying on specific bacterial targets, but its efficacy can be reduced by urine‑alkalinizing agents.

Q: How should methenamine hippurate be stored and handled?

Store methenamine hippurate at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Q: How is methenamine hippurate administered?

Methenamine hippurate is taken orally, usually in tablet form, with or without food as directed by the prescriber. Adequate fluid intake is recommended to ensure proper urinary excretion, and patients may be advised to monitor urine pH to maintain an acidic environment for optimal activation.

Q: What are the most serious risks to watch for while using methenamine hippurate?

Serious adverse reactions, although rare, include anaphylaxis, hemolytic anemia, severe hepatic dysfunction, Stevens‑Johnson syndrome, neutropenia, and acute kidney injury. Patients should seek immediate medical attention if they experience symptoms such as difficulty breathing, severe rash, jaundice, unexplained fatigue, or sudden loss of kidney function.

Q: Who should not use methenamine hippurate?

Methenamine hippurate should be avoided in individuals with severe renal impairment, known hypersensitivity to formaldehyde or related compounds, and in patients whose urine cannot be maintained at an acidic pH (e.g., those on chronic alkalinizing therapy). Consultation with a healthcare professional is essential before starting therapy.

Methenamine Hippurate, the active ingredient in Methenamine Hippurate Eql Pharma, is a urinary antiseptic presented as an oral tablet for oral use. It is employed to prevent recurrent urinary tract infections and to treat uncomplicated urinary tract infections in adults.

GNH India supplies Methenamine Hippurate Eql Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each batch. Customers benefit from reliable delivery timelines and comprehensive post‑sale support.

Manufacturer / TM Owner

Eql Pharma Ab

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Methenamine Hippurate is used within the urinary tract infection prophylaxis pathway to manage bacterial growth in the urinary system.

Prevention of recurrent urinary tract infections: reduces the frequency of infection episodes in individuals with a history of UTIs.
Uncomplicated urinary tract infection: provides antibacterial activity that assists in resolving infection symptoms.
Asymptomatic bacteriuria in selected patients: helps eradicate bacterial colonization to prevent progression to symptomatic infection.

How It Works

After oral administration, methenamine hippurate is excreted unchanged in the urine where, under acidic conditions (pH < 6), it hydrolyzes to release formaldehyde and ammonia. Formaldehyde acts as a broad‑spectrum bactericidal agent, denaturing microbial proteins and nucleic acids, thereby inhibiting bacterial growth in the urinary tract. The generated ammonia also contributes to a hostile environment for many uropathogens, enhancing the overall antiseptic effect.

Side Effects

Methenamine Hippurate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

Nausea: mild stomach upset that may occur after dosing.
Dyspepsia: discomfort or burning sensation in the upper abdomen.
Headache: transient head pain without neurological signs.
Metallic taste: temporary alteration in taste perception.
Urinary irritation: burning or urgency during urination.
Skin rash: mild erythematous eruption on the body.

Serious or Rare Side Effects

Anaphylaxis: severe allergic reaction with airway compromise.
Hemolytic anemia: destruction of red blood cells leading to fatigue.
Hepatic dysfunction: elevated liver enzymes indicating liver injury.
Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement.
Neutropenia: marked reduction in neutrophil count increasing infection risk.
Acute kidney injury: sudden decline in renal function.

Precautions & Warnings

Before initiating methenamine hippurate therapy, several precautions should be considered to ensure safety and effectiveness.

Renal function assessment: evaluate creatinine clearance to confirm adequate urinary excretion.
Urine pH monitoring: maintain acidic urine (pH < 6) for optimal drug activation.
Severe renal impairment avoidance: do not use in patients with markedly reduced kidney function.
Hypersensitivity screening: check for known allergy to formaldehyde or related compounds.
Concomitant alkalinizing agents: avoid drugs that raise urine pH as they diminish efficacy.
Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Methenamine hippurate can interact with other medicines, affecting its antibacterial activity or increasing toxicity.

Major Interactions (Avoid)

Alkalinizing agents (e.g., sodium bicarbonate, potassium citrate): raise urine pH and prevent drug hydrolysis.
Antacids containing magnesium or aluminum: may reduce oral absorption of methenamine.
Renal tubular toxins (e.g., aminoglycosides): increase risk of nephrotoxicity when combined.

Moderate Interactions (Monitor Closely)

Loop diuretics: alter urine concentration, potentially affecting drug efficacy.
Sulfonamide antibiotics: additive risk of hypersensitivity reactions.
Warfarin: possible alteration of INR, requiring closer coagulation monitoring.

Frequently Asked Questions

Methenamine hippurate is used as a urinary antiseptic to prevent recurrent urinary tract infections and to treat uncomplicated urinary tract infections. It works by creating an environment in the urine that is hostile to bacterial growth, helping to reduce infection frequency and aid symptom resolution.

After oral intake, methenamine hippurate is excreted unchanged in the urine. In acidic urine (pH < 6) it hydrolyzes, releasing formaldehyde and ammonia. Formaldehyde acts as a broad‑spectrum bactericidal agent, while ammonia further discourages bacterial survival, together providing antiseptic activity within the urinary tract.

The specific dose of methenamine hippurate is determined by the prescribing healthcare professional based on the patient’s condition, renal function, and urine pH. Dosage regimens may vary, and the prescriber will provide individualized instructions that should be followed exactly.

Safety data for methenamine hippurate in pregnancy and lactation are limited, and the product does not have an established pregnancy category. Healthcare providers should weigh potential benefits against possible risks before prescribing to pregnant or nursing women, and a risk‑benefit assessment is essential.

To place an order, visit the product page on gnhindia.com, submit an enquiry with the required quantity, and provide your institutional or trade credentials. GNH India’s team will verify your details, then respond with pricing, availability, shipping options, and any necessary import documentation.

Methenamine hippurate differs from other urinary antiseptics such as nitrofurantoin or trimethoprim‑sulfamethoxazole in that it requires acidic urine to become active, releasing formaldehyde. This mechanism provides a broad antibacterial effect without relying on specific bacterial targets, but its efficacy can be reduced by urine‑alkalinizing agents.

Store methenamine hippurate at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Methenamine hippurate is taken orally, usually in tablet form, with or without food as directed by the prescriber. Adequate fluid intake is recommended to ensure proper urinary excretion, and patients may be advised to monitor urine pH to maintain an acidic environment for optimal activation.

Serious adverse reactions, although rare, include anaphylaxis, hemolytic anemia, severe hepatic dysfunction, Stevens‑Johnson syndrome, neutropenia, and acute kidney injury. Patients should seek immediate medical attention if they experience symptoms such as difficulty breathing, severe rash, jaundice, unexplained fatigue, or sudden loss of kidney function.

Methenamine hippurate should be avoided in individuals with severe renal impairment, known hypersensitivity to formaldehyde or related compounds, and in patients whose urine cannot be maintained at an acidic pH (e.g., those on chronic alkalinizing therapy). Consultation with a healthcare professional is essential before starting therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 06 Sep 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.